| Product NDC: | 0703-5079 |
| Proprietary Name: | Hetastarch |
| Non Proprietary Name: | Hetastarch |
| Active Ingredient(s): | 6 g/100mL & nbsp; Hetastarch |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0703-5079 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BA740592 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090113 |
| Package NDC: | 0703-5079-37 |
| Package Description: | 12 BAG in 1 CARTON (0703-5079-37) > 500 mL in 1 BAG (0703-5079-31) |
| NDC Code | 0703-5079-37 |
| Proprietary Name | Hetastarch |
| Package Description | 12 BAG in 1 CARTON (0703-5079-37) > 500 mL in 1 BAG (0703-5079-31) |
| Product NDC | 0703-5079 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hetastarch |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090113 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | HETASTARCH |
| Strength Number | 6 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] |